Joong Won Jeon1, Sang Jun Son, Chang Eun Yoo
1School of Chemistry and Center for Molecular Catalysis, Seoul National University, Seoul 151-747, Korea.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers developed a novel catalytic drug that selectively cleaves disease-related proteins. This innovative catalyst targets myoglobin, offering a new approach to therapeutic intervention for protein-related diseases.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: